Publications - GA²LEN Global Network of Excellence

Kolkhir P, Bonnekoh H, Kocatürk E, Hide M, Metz M, Sánchez-Borges M, Krause K, Maurer M.
World Allergy Organ J. 2020 Mar 5;13(3):100107. doi: 10.1016/j.waojou.2020.100107. eCollection 2020 Mar.PMID: 32180892

Clinical experience of a specialized urticaria outpatient clinic from a Portuguese UCARE.

Esteves Caldeira L, Paulino M, Coutinho C, Neto M, Pereira Barbosa M, Costa C.
Eur Ann Allergy Clin Immunol. 2021 May 5. doi: 10.23822/EurAnnACI.1764-1489.209. Online ahead of print. PMID: 33949172

TempTest®: un instrumento de precisión en las urticarias físicas.

Rodrigues-Valle S, Azizi G, Duarte-Dortas S Jr.
Rev Alerg Mex. 2021 Jan-Mar;68(1):2-6. doi: 10.29262/ram.v68i1.827. PMID: 34148323 Spanish.

Expert consensus on practical aspects in the treatment of chronic urticaria.

Bauer A, Dickel H, Jakob T, Kleinheinz A, Lippert U, Metz M, Schliemann S, Schwichtenberg U, Staubach P, Valesky E, Wagner N, Wedi B, Maurer M.
Allergo J Int. 2021;30(2):64-75. doi: 10.1007/s40629-021-00162-w. Epub 2021 Feb 24.
PMID: 33643777 Free PMC article. Review.

Effectiveness of Omalizumab in Patients with Chronic Inducible Urticaria: real-life experience from two UCARE centres.

Can PK, Salman A, Hoşgören-Tekin S, Kocatürk E.
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e679-e682. doi: 10.1111/jdv.17385. Epub 2021 Jun 12.
PMID: 34013560 No abstract available.

Publications until 2020

2020

Is diet partly responsible for differences in COVID-19 death rates between and within countries

The full paper “Is diet partly responsible for differences in COVID-19 death rates between and within countries? “is available here. Bousquet et al. Clin Transl. Allergy (2020) 10:16 https://doi.org/10.1186/s13601-020-00323-0

Important publications on COVID-19

The COVID-19 epidemic is multifactorial but diet has not been sufficiently considered in severity. Geographic differences in COVID-19 mortality suggest the importance of diet. Clinical studies in three patients have contributed to developing a proof-of-concept for the hypothesis that combined Nrf2-TRPA1 foods may be beneficial for some COVID-19 symptoms.

Rapid TRP (transient receptor potential) desensitization in COVID-19: fact or fancy?

A common denominator in all conditions associated with COVID-19 appears to be the oxidative stress storm. Antioxidant nutrients may be of importance in COVID-19 through Nrf2 activation. TRP (Transient Receptor Potential) desensitization has been suggested in 6 COVID-19 patients since broccoli capsules (potent Nrf2 and weak TRPA1 agonist) reduced cough and nasal obstruction within 10-20 minutes. A series of cough induced challenges were carried out in one COVI-19 patient. Curcuma and black pepper, ginger or green tea all improved cough and nasal obstruction in less than 2 minutes.

Jean Bousquet, Wienczyslawa Czarlewski, Torsten Zuberbier, Joaquim Mullol, Hubert Blain, Anna Bedbrook, Piotr Kuna, Josep M Anto

Oral capsaicin induces a very fast improvement in COVID-19 symptoms suggesting TRPV1 channel desensitizatio
TRPA1 and COVID 141020Potential control of COVID-19 symptoms by Nrf2-interacting nutrients with TRPA1 (transient receptor potential ankyrin 1) agonist activityJean Bousquet, Wienczyslawa Czarlewski, Torsten Zuberbier, Joaquim Mullol, Hubert Blain, Raphael de la Torre Anna Bedbrook, Alessandro Fiocchi, Tari Haahtela, Ludger Klimek, Piotr Kuna, Nikolaos Papadopoulos, Aziz Sheikh, Arunas Valiulis, Josep M Anto
COVID-19: Why Germany’s case fatality rate seems so low
Covid-diet CTA
Association fermented foods
Cabbage and fermented vegetables: From death rate heterogeneity in
countries to candidates for mitigation strategies of severe COVID‐19
Nrf2 nutrientsNrf2-TPRA1 interacting nutrients, insulin resistance and COVID-19: Time for research to develop mitigation strategiesJean Bousquet ^(1-3), Jean-Paul Cristol ⁽⁴⁾, Wienczyslawa Czarlewski ^(5-6), Josep M Anto ^(7-10), Adrian Martineau ⁽¹¹⁾, Tari Haahtela ⁽¹²⁾, Susana C Fonseca ⁽¹³⁾, Guido Iaccarino ⁽¹⁴⁾, Hubert Blain ⁽¹⁵⁾, Alessandro Fiocchi ⁽¹⁶⁾, G Walter Canonica ⁽¹⁷⁾, Joao A Fonseca ⁽¹⁸⁾, Alain Vidal ⁽¹⁹⁾, Hak-Jong Choi ⁽²⁰⁾, Hyun Ju Kim ⁽²¹⁾, Vincent Le Moing ⁽²²⁾, Jacques Reynes ⁽²²⁾, Aziz Sheikh ⁽²³⁾, Cezmi A Akdis ⁽²⁴⁾, Torsten Zuberbier⁽¹⁾, and the ARIA group
Clinical caseEfficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental casesJean Bousquet ^1-2, Vincent Le Moing ^3, Hubert Blain ⁴, Wienczyslawa Czarlewski ^5,6, Torsten Zuberbier ¹, Raphael de la Torre^8,9,10, Nieves Pizarro Lozano⁹, Jacques Reynes ³, Anna Bedbrook ^2,6, Jean-Paul Cristol ⁷, Alvaro A. Cruz¹³, Alessandro Fiocchi ¹⁴, Tari Haahtela ¹⁵, Guido Iaccarino¹⁶, Ludger Klimek ¹⁷, Piotr Kuna ¹⁸, Eric Melèn¹⁹, Joaquim Mullol ²⁰, Boleslaw Samolinski ²¹, Arunas Valiulis ²², Josep M Anto ^9-12

Oral capsaicin induces a very fast improvement in COVID-19 symptoms suggesting TRPV1 channel desensitizatio
TRPA1 and COVID 141020Potential control of COVID-19 symptoms by Nrf2-interacting nutrients with TRPA1 (transient receptor potential ankyrin 1) agonist activityJean Bousquet, Wienczyslawa Czarlewski, Torsten Zuberbier, Joaquim Mullol, Hubert Blain, Raphael de la Torre Anna Bedbrook, Alessandro Fiocchi, Tari Haahtela, Ludger Klimek, Piotr Kuna, Nikolaos Papadopoulos, Aziz Sheikh, Arunas Valiulis, Josep M Anto
COVID-19: Why Germany’s case fatality rate seems so low
Covid-diet CTA
Association fermented foods
Cabbage and fermented vegetables: From death rate heterogeneity in
countries to candidates for mitigation strategies of severe COVID‐19
Nrf2 nutrientsNrf2-TPRA1 interacting nutrients, insulin resistance and COVID-19: Time for research to develop mitigation strategiesJean Bousquet ^(1-3), Jean-Paul Cristol ⁽⁴⁾, Wienczyslawa Czarlewski ^(5-6), Josep M Anto ^(7-10), Adrian Martineau ⁽¹¹⁾, Tari Haahtela ⁽¹²⁾, Susana C Fonseca ⁽¹³⁾, Guido Iaccarino ⁽¹⁴⁾, Hubert Blain ⁽¹⁵⁾, Alessandro Fiocchi ⁽¹⁶⁾, G Walter Canonica ⁽¹⁷⁾, Joao A Fonseca ⁽¹⁸⁾, Alain Vidal ⁽¹⁹⁾, Hak-Jong Choi ⁽²⁰⁾, Hyun Ju Kim ⁽²¹⁾, Vincent Le Moing ⁽²²⁾, Jacques Reynes ⁽²²⁾, Aziz Sheikh ⁽²³⁾, Cezmi A Akdis ⁽²⁴⁾, Torsten Zuberbier⁽¹⁾, and the ARIA group
Clinical caseEfficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental casesJean Bousquet ^1-2, Vincent Le Moing ^3, Hubert Blain ⁴, Wienczyslawa Czarlewski ^5,6, Torsten Zuberbier ¹, Raphael de la Torre^8,9,10, Nieves Pizarro Lozano⁹, Jacques Reynes ³, Anna Bedbrook ^2,6, Jean-Paul Cristol ⁷, Alvaro A. Cruz¹³, Alessandro Fiocchi ¹⁴, Tari Haahtela ¹⁵, Guido Iaccarino¹⁶, Ludger Klimek ¹⁷, Piotr Kuna ¹⁸, Eric Melèn¹⁹, Joaquim Mullol ²⁰, Boleslaw Samolinski ²¹, Arunas Valiulis ²², Josep M Anto ^9-12

2013

The EAACI/GA²LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

This Guideline is the result of a systematic literature review using the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA2LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The life-time prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria do not only cause a decrease in quality of life, but also affect performance at work and school and, as such, are members of the group of severe allergic diseases. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS).

The Methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin.

2012

Does Pet Ownership in Infancy Lead to Asthma or Allergy at School Age? Pooled Analysis of Individual Participant Data from 11 European Birth Cohorts

Lødrup Carlsen KC, Roll S, Carlsen K-H, Mowinckel P, Wijga AH, et al. (2012) Does Pet Ownership in Infancy Lead to Asthma or Allergy at School Age? Pooled Analysis of Individual Participant Data from 11 European Birth Cohorts. PLoS ONE 7(8): e43214. doi:10.1371/journal.pone.0043214

Chronic rhinosinusitis and occupational risk factors among 20- to 75-year-old Danes—A GA²LEN-based study

Thilsing, T., Rasmussen, J., Lange, B., Kjeldsen, A. D., Al-Kalemji, A. and Baelum, J. (2012), Chronic rhinosinusitis and occupational risk factors among 20- to 75-year-old Danes—A GA2LEN-based study. Am. J. Ind. Med., 55: 1037–1043. doi: 10.1002/ajim.22074

Asthma in adults and its association with chronic rhinosinusitis: The GA²LEN survey in Europe

Jarvis D, Newson R, Lotvall J, Hastan D, Tomassen P, Keil T, Gjomarkaj M, Forsberg B, Gunnbjornsdottir M, Minov J, Brozek G, Dahlen SE, Toskala E, Kowalski ML, Olze H, Howarth P, Krämer U, Baelum J, Loureiro C, Kasper L, Bousquet PJ, Bousquet J, Bachert C, Fokkens W, Burney P. Asthma in adults and its association with chronic rhinosinusitis: The GA2LEN survey in Europe. Allergy 2012; 67: 91–98. Allergy, 67: 91–98. doi: 10.1111/j.1398-9995.2011.02709.x

Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA²LEN – ARIA Position Paper

Correspondence author Prof. Jean Bousquet. Int Arch Allergy Immunol 2012;158:216-231 (DOI: 10.1159/000332924)

A Summary of the New International EAACI/GA²LEN/EDF/WAO Guidelines in Urticaria

Zuberbier, Torsten MD. World Allergy Organization Journal: January 2012 – Volume 5 – Issue – p S1–S5, doi: 10.1097/WOX.0b013e3181f13432

Practical guide to skin prick tests in allergy to aeroallergens

Bousquet, J., Heinzerling, L., Bachert, C., Papadopoulos, N. G., Bousquet, P. J., Burney, P. G., Canonica, G. W., Carlsen, K. H., Cox, L., Haahtela, T., Lodrup Carlsen, K. C., Price, D., Samolinski, B., Simons, F. E. R., Wickman, M., Annesi-Maesano, I., Baena-Cagnani, C. E., Bergmann, K. C., Bindslev-Jensen, C., Casale, T. B., Chiriac, A., Cruz, A. A., Dubakiene, R., Durham, S. R., Fokkens, W. J., Gerth-van-Wijk, R., Kalayci, O., Kowalski, M. L., Mari, A., Mullol, J., Nazamova-Baranova, L., O’Hehir, R. E., Ohta, K., Panzner, P., Passalacqua, G., Ring, J., Rogala, B., Romano, A., Ryan, D., Schmid-Grendelmeier, P., Todo-Bom, A., Valenta, R., Woehrl, S., Yusuf, O. M., Zuberbier, T. and Demoly, P. (2012) ARIA and GA²LEN members. In collaboration with the World Health Organization Collaborating Center for Asthma and Rhinitis, Montpellier.. Allergy, 67: 18–24. January 2012doi: 10.1111/j.1398-9995.2011.02728.x

Mentions

Europe

Launch of the GA²LEN Pollen Chamber
Validation of the Global Allergy and Asthma European Network (GA²LEN) chamber for trials in allergy: Innovation of a mobile allergen exposure chamber
Sciencedirect.com
www.mendeley.com
https://refubium.fu-berlin.de/handle/fub188/23464
umweltbundesamt.de
GA²LEN ACARE Network
Global online open accesshttps://haei.org/a-new-global-network-of-specialized-treatment-centers-becomes-a-reality/

2011

Increased Prevalence of Symptoms of Rhinitis but Not of Asthma between 1990 and 2008 in Swedish Adults: Comparisons of the ECRHS and GA²LEN Surveys

Anders Bjerg, Linda Ekerljung, Roelinde Middelveld, Sven-Erik Dahlen, Bertil Forsberg, Karl Franklin, Kjell Larsson, Jan Lotvall, Inga Sif O´Lafsdo´ttir, Kjell Toren, Bo Lundback, Christer Janson. PLoS ONE 6(2): e16082. doi:10.1371/journal.pone.0016082

Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA(#) and GA²LEN/HANNA

Kowalski ML, Makowska JS, Blanca M, Bavbek S, Bochenek G, Bousquet J, Bousquet P, Celik G, Demoly P, Gomes ER, Niżankowska-Mogilnicka E, Romano A, Sanchez-Borges M, Sanz M, Torres MJ, De Weck A, Szczeklik A, Brockow K. Allergy. 2011 Jul;66(7):818-29. doi: 10.1111/j.1398-9995.2011.02557.x. Epub 2011 Feb 14.

Use of a common food frequency questionnaire (FFQ) to assess dietary patterns and their relation to allergy and asthma in Europe: pilot study of the GA²LEN FFQ

Garcia-Larsen V, Luczynska M, Kowalski ML, Voutilainen H, Ahlström M, Haahtela T, Toskala E, Bockelbrink A, Lee HH, Vassilopoulou E, Papadopoulos NG, Ramalho R, Moreira A, Delgado L, Castel-Branco MG, Calder PC, Childs CE, Bakolis I, Hooper R, Burney PG; GA2LEN-WP 1.2 ‘Epidemiological and Clinical Studies’. Eur J Clin Nutr. 2011 Jun;65(6):750-6. Epub 2011 Mar 23.

Mentions

Europe

Creation of GA²LEN Wikipedia page – Global open access

2010

GA²LEN Position Paper: Risk of first-generation H1-antihistamines

M. K. Church, M. Maurer, F. E. R. Simons, C. Bindslev-Jensen, P. van Cauwenberge, J. Bousquet, S. T. Holgate & T. Zuberbier. Allergy (2010) DOI:10.1111/j.1398-9995.2009.02325.x

Self-reported asthma and allergies in top athletes compared to the general population – results of the German part of the GA²LEN-Olympic study 2008

Thomas S, Wolfarth B, Wittmer C, Nowak D, Radon K; GA2LEN-Olympic study-Team. Allergy Asthma Clin Immunol. 2010 Nov 30;6(1):31.

Multi-symptom asthma is closely related to nasal blockage, rhinorrhea and symptoms of chronic rhinosinusitis-evidence from the West Sweden Asthma Study

Lötvall J, Ekerljung L, Lundbäck B. Respir Res. 2010 Nov 26;11:163.

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA²LEN paper

Bousquet J, Schünemann HJ, Zuberbier T, Bachert C, Baena-Cagnani CE, Bousquet PJ, Brozek J, Canonica GW, Casale TB, Demoly P, Gerth van Wijk R, Ohta K, Bateman ED, Calderon M, Cruz AA, Dolen WK, Haughney J, Lockey RF, Lötvall J, O’Byrne P, Spranger O, Togias A, Bonini S, Boulet LP, Camargos P, Carlsen KH, Chavannes NH, Delgado L, Durham SR, Fokkens WJ, Fonseca J, Haahtela T, Kalayci O, Kowalski ML, Larenas-Linnemann D, Li J, Mohammad Y, Mullol J, Naclerio R, O’Hehir RE, Papadopoulos N, Passalacqua G, Rabe KF, Pawankar R, Ryan D, Samolinski B, Simons FE, Valovirta E, Yorgancioglu A, Yusuf OM, Agache I, Aït-Khaled N, Annesi-Maesano I, Beghe B, Ben Kheder A, Blaiss MS, Boakye DA, Bouchard J, Burney PG, Busse WW, Chan-Yeung M, Chen Y, Chuchalin AG, Costa DJ, Custovic A, Dahl R, Denburg J, Douagui H, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Kaliner MA, Keith PK, Kim YY, Klossek JM, Kuna P, Le LT, Lemiere C, Lipworth B, Mahboub B, Malo JL, Marshall GD, Mavale-Manuel S, Meltzer EO, Morais-Almeida M, Motala C, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Ouedraogo S, Palkonen S, Popov TA, Price D, Rosado-Pinto J, Scadding GK, Sooronbaev TM, Stoloff SW, Toskala E, van Cauwenberge P, Vandenplas O, van Weel C, Viegi G, Virchow JC, Wang DY, Wickman M, Williams D, Yawn BP, Zar HJ, Zernotti M, Zhong N; In collaboration with the WHO Collaborating Center of Asthma and Rhinitis (Montpellier). Allergy. 2010 Oct;65(10):1212-21.

Global Allergy and Asthma European Network (GA²LEN) addresses the epidemic of allergy and asthma

Panzer PC, van Cauvenberg P, Bousquet J. Cas Lek Cesk. 2010;149(1):32-7. Review. Czech.

Problematic severe asthma in children, not one problem but many: a GA²LEN initiative

Hedlin G, Bush A, Lødrup Carlsen K, Wennergren G, De Benedictis FM, Melén E, Paton J, Wilson N, Carlsen KH; Problematic Severe Asthma in Childhood Initiative group. Eur Respir J. 2010 Jul;36(1):196-201. Review.

The management of the allergic child at school: EAACI/GA²LEN Task Force on the allergic child at school

Muraro A, Clark A, Beyer K, Borrego LM, Borres M, Lødrup Carlsen KC, Carrer P, Mazon A, Rancè F, Valovirta E, Wickman M, Zanchetti M. Allergy. 2010 Jun 1;65(6):681-9. Epub 2010 Mar 25. Allergy 2010; DOI: 10.1111/j.1398-9995.2010.02343.x

Mentions

Europe

Achtung! Older allergy drugs may be dangerous
Cordis News; translated in FR, DE, IT, ES, PL”
“First Generation Antihistamines’ “”Unwanted Effects”” Prompt Caution. (Elsevier business intelligence publication on non- prescription pharmaceuticals and nutritionals)”
ALLERGIE, ATTENZIONE AI ‘VECCHI’ ANTISTAMINICI, AGI Salute (Agenzia Giornalistica Italia press agency)
“Allergie:Attenti agli antistaminici di vecchia generazione LiberoReporter.It – News online”
Dangers Of Older Allergy Drugs Often Underestimated And Overlooked – Medical News Today
www.sciencedaily.com
www.pharmanews.eu
www.pharmQD.com
Risks of first-generation antihistamines, GA²LEN News
EAACI website – www.eaaci.net

2009

EAACI/GA²LEN/EDF/WAO guideline: management of urticaria

T. Zuberbier, R. Asero, C. Bindslev-Jensen, G. Walter Canonica,M. K. Church, A. M. Giménez-Arnau, C. E. H. Grattan, A. Kapp,M. Maurer, H. F. Merk, B. Rogala,S. Saini, M. Sánchez-Borges, P. Schmid-Grendelmeier,H. Schϋnemann, P. Staubach,G. A. Vena, B. Wedi.

Position paper

GA²LEN (Global Allergy and Asthma European Network), the perspective of the German speaking centers

Wöhrl S, Radon K, Ring J, Moritz K, Akdis C, Burney P, Van Cauwenberge P, Bousquet J, Zuberbier T. Wien Klin Wochenschr. 2009;121(17-18):589-97. German.

Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA²LEN platform

The Galenda project P.-J. Bousquet, P. Demoly,A. Romano, W. Aberer,A. Bircher, M. Blanca, K. Brockow,W. Pichler, M. J. Torres, I. Terreehorst, B. Arnoux, M. Atanaskovic-Markovic, A. Barbaud, A. Bijl, P. Bonadonna, P. G. Burney, S. Caimmi, G. W. Canonica, J. Cernadas, B. Dahlen, J.-P. Daures, J. Fernandez, E. Gomes, J.-L. Gueant, M. L. Kowalski, V. Kvedariene, P.-M. Mertes, P. Martins, E. Nizankowska-Mogilnicka, N. Papadopoulos, C. Ponvert, M. Pirmohamed, J. Ring, M. Salapatas, M. L. Sanz, A. Szczeklik, E. Van Ganse, A. L. De Weck, T. Zuberbier, H. F. Merk, B. Sachs, A. Sidoroff, Global Allergy, Asthma European Network (GA2LEN) and Drug Allergy and Hypersensitivity Database (DAHD) and the European Network for Drug Allergy (ENDA). Allergy (2009), 64:2, doi: 10.1111/j.1398-9995.2008.01944.x

Establishing a standardized quality management system for the European Health Network GA²LEN

Heinzerling L, Burbach G, van Cauwenberge P, Papageorgiou P, Carlsen KH, Lødrup Carlsen KC, Zuberbier T.Allergy. 2010 Jun 1;65(6):743-52. Epub 2009 Nov 3.

The CONSORT statement checklist in allergen-specific immunotherapy: a GA²LEN paper

Bousquet PJ, Brozek J, Bachert C, Bieber T, Bonini S, Burney P, Calderon M, Canonica GW, Compalati E, Daures JP, Delgado L, Demoly P, Dahl R, Durham SR, Kowalski ML, Malling HJ, Merk H, Papadopoulos N, Passalacqua G, Simon HU, Worms M, Wahn U, Zuberbier T, Schünemann HJ, Bousquet J. Allergy. 2009 Dec;64(12):1737-45. Epub 2009 Oct 26.

GA²LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients

Bousquet PJ, Burbach G, Heinzerling LM, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet-Rouanet L, Demoly P, Bresciani M, Bruno A, Gjomarkaj M, Canonica GW, Darsow U, Durham S, Fokkens WJ, Giavi S, Gramiccioni C, Papadopoulos NG, Haahtela T, Kowalski ML,Magyar P, Muraközi G, Orosz M, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Bousquet J, Zuberbier T.Allergy. 2009 Nov;64(11):1656-62.

The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA²LEN meta-analysis

Compalati E, Passalacqua G, Bonini M, Canonica GW. Allergy. 2009 Nov;64(11):1570-9. Epub 2009 Sep 30. Review.

The definition and diagnostic testing of physical and cholinergic urticarias–EAACI/GA²LEN/EDF/UNEV consensus panel recommendations

Magerl M, Borzova E, Giménez-Arnau A, Grattan CE, Lawlor F, Mathelier-Fusade P, Metz M, Młynek A, Maurer M; EAACI/GA2LEN/EDF/UNEV. Allergy. 2009 Dec;64(12):1715-21. Epub 2009 Sep 30.

GA²LEN (Global Allergy and Asthma European Network)

Bousquet J, Kauffmann F, Demoly P, Leynaert B, Bousquet PJ, Demenais F, Lenzen G, Burney PG, Zuberbier T, Van Cauwenberge P. Rev Mal Respir. 2009 Jun;26(6):577-86. French.

Mentions

Europe

Carlsen KH, Delgado L. Asthma, Bronchial Hyperresponsiveness and Sports.
World Allergy Organization.
Allergy Diseases Resource Center
Allergic rhinitis: how to pinpoint SCUAD patients, Interview Prof. J Bousquet. Expression magazine – International Industry News Press release edited by Stallergènes
A European Agenda for Asthma and Allergies, Event in the European Parliament
The British agenda for asthma and allergies: A breakfast roundtable to highlight and debate the UK’s asthma and allergy policies – Westminster, London 2009

2008

Pan-European harmonisation of skin prick testing: GA²LEN study reveals novel sensitisation patterns for inhalant allergens in Europe

Guido J. Burbach1+, Lucie M. Heinzerling1+, Günter Edenharter1§, Claus Bachert2, Carsten Bindslev-Jensen3, Jean Bousquet4, Laure Bousquet-Rouanet4, Andreina Bruno5, Giorgio Walter Canonica6, Ulf Darsow7, Pascal Demoly4, Stephen Durham8, Wytske J Fokkens9, Stavroula Giavi10, Mark Gjomarkaj5, Tari Haahtela11, Marek L Kowalski12, Pál Magyar13, Gabriella Muraközi13, Marta Orosz13, Nikolaos G Papadopoulos10, Claudia Röhnelt1, Georg Stingl14, Ana Todo-Bom15, Erika von Mutius16, Alice Wiesner17, Stefan Wöhrl14, Torsten Zuberbier1*

The German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findings.

A. Młynek, M. Magerl, M. Hanna, S. Lhachimi, I. Baiardini, G. W. Canonica, Z. Brzoza, A. Kasperska-Zajac, B. Rogala, A. Zalewska-Janowska, T. Zuberbier , M. Maurer.
Allergy 2008 DOI: 10.1111/j.1398-9995.2008.01914.x

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA²LEN and AllerGen).

“Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O’Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D; World Health Organization; GA²LEN; AllerGen.
Impact Factor: 5.014, ranks 2nd of 17 in the Allergy category; 16 of 119 in the Immunology category.

European Academy of Allergy and Clinical Immunology. Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN

Carlsen KH, Anderson SD, Bjermer L, Bonini S, Brusasco V, Canonica W, Cummiskey J, Delgado L, Del Giacco SR, Drobnic F, Haahtela T, Larsson K, Palange P, Popov T, van Cauwenberge P; European Respiratory Society;
Allergy 2008, Vol 63, Issue 4, pp. 387-403. Review.”
Impact Factor: 5.014, ranks 2nd of 17 in the Allergy category; 16 of 119 in the Immunology category.

Meta-analysis of determinants for pet ownership in 12 European birth cohorts on asthma and allergies: a GA²LEN initiative

Eller E, Roll S, Chen CM, Herbarth O, Wichmann HE, von Berg A, Krämer U, Mommers M, Thijs C, Wijga A, Brunekreef B, Fantini MP, Bravi F, Forastiere F, Porta D, Sunyer J, Torrent M, Høst A, Halken S, Lødrup Carlsen KC, Carlsen KH, Wickman M, Kull I, Wahn U, Willich SN, Lau S, Keil T, Heinrich J; Working Group of GA2LEN–Work Package 1.5 Birth Cohorts. Allergy. 2008 Nov;63(11):1491-8

Important research questions in allergy and related diseases: nonallergic rhinitis: a GA²LEN paper

Bousquet J, Fokkens W, Burney P, Durham SR, Bachert C, Akdis CA, Canonica GW, Dahlen SE, Zuberbier T, Bieber T, Bonini S, Bousquet PJ, Brozek JL, Cardell LO, Crameri R, Custovic A, Demoly P, van Wijk RG, Gjomarkaj M, Holland C, Howarth P, Humbert M, Johnston SL, Kauffmann F, Kowalski ML, Lambrecht B, Lehmann S, Leynaert B, Lodrup-Carlsen K, Mullol J, Niggemann B, Nizankowska-Mogilnicka E, Papadopoulos N, Passalacqua G, Schünemann HJ, Simon HU, Todo-Bom A, Toskala E, Valenta R, Wickman M, Zock JP.Allergy. 2008 Jul;63(7):842-53. Review.

The relation between paracetamol use and asthma: a GA²LEN European case-control study

Shaheen S,Potts J, Gnatiuc L, Makowska J, Kowalski ML, Joos G, van Zele T, van Durme Y, De Rudder I, Wöhrl S, Godnic-Cvar J, Skadhauge L, Thomsen G, Zuberbier T, Bergmann KC, Heinzerling L, Gjomarkaj M, Bruno A, Pace E, Bonini S, Fokkens W, Weersink EJ, Loureiro C, Todo-Bom A, Villanueva CM, Sanjuas C, Zock JP, Janson C, Burney P; Selenium and Asthma Research Integration project; GA2LEN. Eur Respir J. 2008 Nov;32(5):1231-6. Epub 2008 Jun 25.

ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA²LEN review

Baiardini I, Braido F, Tarantini F, Porcu A, Bonini S, Bousquet PJ, Zuberbier T, Demoly P, Canonica GW; GA2LEN. Allergy. 2008 Jun;63(6):660-9. Review.

Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA²LEN

Carlsen KH, Anderson SD, Bjermer L, Bonini S, Brusasco V, Canonica W, Cummiskey J, Delgado L, Del Giacco SR, Drobnic F, Haahtela T, Larsson K, Palange P, Popov T, van Cauwenberge P; European Review.

Impact of gender on asthma in childhood and adolescence: a GA²LEN review

Almqvist C, Worm M, Leynaert B; working group of GA2LEN WP 2.5 Gender. Allergy. 2008 Jan;63(1):47-57. Epub 2007 Sep 5. Review.

Mentions

Germany

Experten erwarten für diesen Frühling besonders viele Birkenpollen – GA²LEN
Paracetamol erhöht Ashtma-Risiko um das Dreifache, Euroäische Studie bestätigt Zusammenhang zwischen allergie und Schmerzmitteleinnahme
www.scienexx.de
Urtikaria: Ein Medikament für alle Formen der Erkrankung, Berliner Ärtzblatt, pp.26-27

Europe

Report on Allergy Schools: “GA²LEN/EAACI Summer School Recombinant Allergens: From Fundamental Aspects To Clinical Applications, Bischoffsheim, France” + “GA²LEN/EAACI Allergy School St Catherine’s College, Oxford, UK” + PAPRICA Symposia in Lithuania + and Back cover ” “Committed to Integration and Sustainability”
Press conference, launch of the campaign “Does rhinitis lead to asthma?” in Belgium (FR and NL).
Link to GA²LEN website, Health-EU newsletter for World Asthma Day
Sport and asthma: GA²LEN researchers follow European Olympic athletes to Beijing – Articles by news agencies Reuters, AP, AFP, Lusa, EINNews.com
EU researchers to study asthma at Olympics, also included in EurActiv Science and Research
Sport and asthma: GA²LEN researchers follow European Olympic athletes to Beijing, Health-EU Portal, News
Asma: Estudo europeu vai avaliar prevalência em atletas apurados para Pequim 2008, Noticias Sapo
Beijing pollution no added risk for asthma athletes www.mirror.co.uk
EU researchers to assess rates of asthma among Olympic athletes, Cordis News
Scientists to study asthma among athletes
Sport and asthma: GA²LEN researchers follow European Olympic athletes to Beijing, MedicalNewsToday.com;
EU researchers to assess rates of asthma among Olympic athletes.
Scientists propose creating unique identification codes for biobanks, Cordis News + EC website e-newsletter
Tracing biobanks: EU researchers propose identifying DNA collections as books
Allergy School series kick-off, Announcement of GA²LEN Allergy Schools, Cordis News, Cordis Events
Announcement of GA²LEN Allergy Schools on GABRIEL website
Essex Pharma industry press release on IDEAL/ GA²LEN Allergy School
Allergic rhinitis diagnosis and treatment: new guidelines for primary care professionals
www.globalfamilydoctor.org
WONCA Network website
MedicalNewsToday.com
www.innocationsreport.de
New guidelines for handling hay fever, Cordis News
Atletas olímpicos em estudo sobre incidëncia da asma, Jornal de Norícias
GA²LEN Researchers Follow European Olympic Athletes To Beijing To Assess Diagnosis Rates Of Asthma And Allergies
GA²LEN researchers follow European Olympic Athletes to Beijing to assess diagnosis rates of asthma
Crise asmática ataca atletas de comtiva portuguesa, Jornal de Angola online
Link between paracetamol and asthma in European adults confirmed by GA²LEN study
Study links paracetamol use to asthma, Boehringer Ingelheim Industry news webpage
Regular paracetamol use ups asthma risks,
Paracetamol linked to asthma,
Paracetamol and asthma,
Paracetamol, Asthma Link,
Paracetamol usage can lead to asthma: Study,
Taking paracetamol regularly ‘triples risk of asthma’, Dods Paracetamol en astma: oorzak – gevolg,
Taking paracetamol regularly ‘triples risk of asthma’, Daily Mail (Mail Online, www.dailymail.co.uk)
Paracetamol given to babies is linked to global rise in asthma, The Independent, p. 8
Regular acetaminophen use Triples Asthma Risk, www.newsmax.com
Interview with Prof. Shaheen, GMTV radio, following press release on paracetamol use and asthma
Erhöhtes Asthmarisiko durch Paracetamol, FAZ, p. 1
Researchers link asthma with paracetamol, Nursing Times.net
More Europeans Likely To Suffer From Ragweed Allergy in English, and French
Science for Environment Policy’, Issue 150: a service from the European Commission, DG Environment Common invasive weed brings hay-fever allergies to Europe

France

Asthme et allergies, le paracétamol en cause, Le Nouvel Observateur, Sciences et Avenir
Asthme – Des traitements à éviter chez les nouveau-nés, France-Soir, n°19910, page 9
Campagne européene “de la rhinite à l’asthme”: Pensez-vous être à l’abri des allergies? – Announcement of GA²LEN Symposium in Brussels on 26 April 2008, Le Journal du Médecin, 18 March 2008, p.8

2007

Does rhinitis lead to asthma?

Van Cauwenberge P, Watelet JB, Van Zele T, Wang DY, Toskala E, Durham S, Fokkens W, Lau S, Leynaert B, Wickman M, Salapatas M, Burney P, Mullol J; GA2LEN workpackages 3.2 and 3.3.Rhinology. 2007 Jun;45(2):112-21. Review.

Eczematous reactions to food in atopic eczema: position paper of the EAACI and GA²LEN.

Werfel T, Ballmer-Weber B, Eigenmann PA, Niggemann B, Rancé F, Turjanmaa K, Worm M. Allergy. 2007 Jul;62(7):723-8.

EAACI/GA²LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity

Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczyńska M, Picado C, Scadding G, Kowalski ML, Setkowicz M, Ring J, Brockow K, Bachert C, Wöhrl S, Dahlén B, Szczeklik A. Allergy. 2007 Oct;62(10):1111-8. Epub 2007 May 22. Review.

Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA²LEN and InterAirways document

Papadopoulos NG, Xepapadaki P, Mallia P, Brusselle G, Watelet JB, Xatzipsalti M, Foteinos G, van Drunen CM, Fokkens WJ, D’Ambrosio C, Bonini S, Bossios A, Lötvall J, van Cauwenberge P, Holgate ST, Canonica GW, Szczeklik A, Rohde G, Kimpen J, Pitkäranta A, Mäkelä M, Chanez P, Ring J, Johnston SL. Allergy. 2007 May;62(5):457-70. Epub 2007 Feb 27. Review.

Mentions

Germany

Wirkungsverständnis normaler Erkältung könnte neuen Ansatz zur Beherrschung von Asthmaanfällen liefern
www.med-kollege.de
mysan.de
www.campus-med.de
FinanzNachichten.de
PR-inside.com
www.Juraforum.de
Wirkungsverständnis von Erkältungen könnte neuen Ansatz zur Beherrschung von Asthmaanfällen liefern — www.journalMED.de (Info für Ärtze section)
“Führt Rhinitis zu Asthma? GA²LEN Kampagne”
www.presseportal.de
www.pr-inside.com (de)
www.presseecho.de
www.finanznachrichten.de
www.f-tor.de, www.stiftungen.de
www.news-und-trends.de
www.messe.at
“EU-Mitgliedsländer sollen Kampf gegen Allergien forcieren” Ärzte Zeitung
www.aertztezeitung.de
Europäische Wissenschaftler fordern eine systematischere Diagnose der überempfindichkeit gegen Aspirin und veröffentlichen neue Konsensusrichtilinien zur Diagnosefindung.
www.presseportal.de
www.ots.at
www.cecu.de
Das europäisches Exzellenz-Netzwerk GA²LEN (Global Allergy and Asthma European Network) zertifiziert di Ulmer Allergologie der Universitätsklinik für Dermatologie und Allergology — IDW website Informationdienst Wissenschaft

Europe

Understanding mechanisms of common colds: a new approach to help control asthma attacks (EN, FR, DE, ES)
A European Summit on Public Health: Allergic diseases: Minor irritation or major aggravation?
Brussels, Belgium. Host: MEP John Bowis
Understanding mechanisms of Common colds: a new approach to help control asthma attacks — PRNewswire in English, French, Spanish, German
www.prnewswire.co.uk
www.perssupport.nl www.europapress.es www.pressportal.de
www.ft.com www.factiva.com
www.lexisnexis.com
www.ots.de
www.newsaktuelle.de newsaktuelle Schweiz www.pressemeldinger.no
CORDIS News (PL: Zdaniem naukowcó potrzebne sa nowe metody leczenia ataków astmy – IT: Secondo i ricercatori cono necessari nuovi approcci per trattare gli attacchi d’asma — FR: De nouvelles approches nécessaires pour le tratement des crises d’asthme, déclarent les chercheurs — ES: Los investigadores afirman que se necesitan planteamientos nuevos para tratar los ataques de asma)
Understanding mechanisms of Common colds: a new approach to help control asthma attacks. Posted on AlphaGalileo – Alphagalileo.org over 6,000 science journalists registered
Understanding mechanisms of Common colds: a new approach to help control asthma attacks.
www.earthtimes.org
www.pr-inside.com
www.innovations-report.de
Understanding mechanisms of common colds: a new approach to help control asthma attacks — disseminated by Allergy journal email alerts + displayed in Highlights of the Journal homepage
Research review, half a page “Continuity needed to fight allergic diseases” (Issue 1, March 2007, p66)
Announcement of GA²LEN public day “Living with Allergy” on CORDIS News
Asthma and allergy research explored at European conference – Asthma UK media release
“Leidt rinitis tot astma. GA²LEN campagne”
www.perssupport.nl (ANP news agency)
www.nieuwsbank.nl
www.pressreleases.be (Belga news agency
www.zita.be
Produce la rinitis asma? Campaña GA²LEN
http://.actualitad.terra.es
www.europapress.es
www.eleconomista.es
www.invertia.com
www.infomercados.com
www.basefinanciera.com
Media release GA²LEN Campaign, Does Rhinitis lead to Asthma? (GA²LEN Campaign European launch)
GA²LEN Annual Meeting, London, UK – Public day in Collaboration with EFA, Asthma UK, Allergy UK
Does rhinitis lead to asthma? GA²LEN campaign — in 5 languages,
www.prnewswire.co.uk
http://uk.biz.yahoo.com
www.ft.com
www.factiva.com
www.lexisnexis.com
www.newsratings.com
www.investigate.co.uk
www.pr-inside.com (de)
www.earthtimes.org
www.pressreleases.be (Belga agency)
www.pressemeldinger.no
“New campaign highlight’s rhinitis-asthma link, CORDIS News in 5 languages: EN, DE, ES, FR, IT, PL
Media invitation GA²LEN Annual meeting, London, UK + Press kits “Understanding allergic diseases to curb the epidemics” – “Why research on allergy and asthma?”
Animated (Flash) banner on the GA²LEN homepage for the campaign “Does rhinitis lead to asthma?”
“A breath of hope, Researchers are combining their efforts to study the genetic and environmental factors in asthma” EMBO Report Vol 8, N°4, 2007, Science & Society, European Molecular Biology Organisation (EMBO) – GA²LEN (as well as GABRIEL)
GA²LEN Open day on Asthma UK website, Events diary –also announced on IPCRG website, EFA website, EAACI website, EuroPrevall website and others: www.gate2biotech.com, “Medical industry Email News Service”
European Scientists call for more systematic diagnosis of aspirin hypersensitivity and publish new consensus guidelines on how diagnose — PRNewswire and network: www.prnewswire.co.uk in EN, DE, ES, FR; www.europapress.es, http://uk.biz.yahoo.com; www.perssupport.nl; www.ft.com; www.factiva.com; www.lexisnexis.com, www.pressemeldinger.no, www.earthtimes.org, www.immediapress.it, www.physorg.com, www.innovations-report.com
Científicos europeos piden un dianoóstico más sistemático de la hipersensitividad a la aspirina – www.eleconomista.es
“Event” on AlphaGalileo website, GA²LEN Symposium at the EAACI congress.
“European Scientists call for more systematic diagnosis of aspirin hypersensitivity and publish new consensus guidelines on how diagnose – Published online this month in Allergy” – Blackwell Allergy e-alerts.
Launch of the Brussels Declaration of Asthma Management, European Parliament, Brussels GA²LEN
Does rhinitis lead to Asthma? GA²LEN reviews the scientific evidence — Symposium, GA²LEN fills the gap: rhinitis and asthma, Sunday 10 June 2007, 3.30-5.00 pm, EAACI Congress Gothenburg 2007, Sweden
Kan “hösnuva” leda till astma? GA²LEN ger en översikt av det vetenskapliga kunskapsläget
Latest update of Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines – Press conference at the EAACI Congress Göteborg – presenting ARIA update in collaboration with GA²LEN
New Allergic Rhinitis And Its Impact on Asthma (ARIA) Guideline Urges Doctors To Make A Stronger Link Between Rhinitis And Asthma
BBC World Service – GA²LEN. Peter Day, on what is happening in the pharmaceutical industry
ALK-Abelló, the makers of GRAZAX, welcome GA²LEN new hay fever and asthma campaign
GA²LEN and GA²LEN campaign in Issue 0 of the Health-EU Newsletter (DG SANCO)
GA²LEN campaign highlights links between rhinitis and asthma, Blackwell Publishing, Leading Edge, Issue 2 July 2007 (quarterly)
EAACI NL September 2007 + back cover page of GA²LEN Campaign “Does rhinitis lead to asthma?”, brochures in several languages + Report on PAPRICA Symposia in the Netherlands
EAACI NL September 2007 – Announcement GA²LEN Campaign “Does rhinitis lead to asthma?” messages and translations
Allergic rhinitis and asthma: International recommendations available to patients and health professionals in 10 languages AlphaGalileo.org
Allergic rhinitis and asthma: International recommendations available to patients and health professionals in 10 languages
Blackwell Publishing Allergy Journal homepage: highlights
Allergic rhinitis and asthma: International recommendations available to patients and health professionals in 10 languages
Does rhinitis lead to asthma? Patient brochure on the UCB website www.todaysallergies.com
Media invitation to the Open Forum on the Future of Networks of Excellence, October 2007
“Quatre” Newsletter of Allergique.org 8 November 2007: ARIA recommendations
Media invitation: Open Forum on the Future of Networks of Excellence – AlphaGalileo
Press kit for the Open Forum on the Future of Networks of Excellence in collaboration with CASCADE Network of Excellence.
EU research networks threatened by lack of funding, EurActiv.com
Announcement of the Open Forum on the Future of Networks of Excellence on websites: www.projectia.fi, http://fellownet.embo.org, www.score-project.eu, University of Munich website, www.ipr-helpdesk.org, www.tekes.fi, www.ipi.it, INSME.org (international network of SMEs)
EU Lithuania – access for healthcare professionals and pharmaceutical industry
“Biologijos, medicinos ir geomokslu skyriuje. Nuo alerginio rinito iki astmos. (Launch of GA²LEN campaign ‘Does rhinitis lead to asthma?’)
Lietuvos Mokslu Akademijos Zinios, N°4 (47) – Kaunas University magazine”
“Study links Mediterranean diet in pregnancy to reduced asthma and allergy risk in children, CORDIS News – Article on research study from NewGeneris (‘Newborns and genotoxic exposure risks’) and GA2LEN (‘Global allergy and asthma European network’) projects”

France

De nouvelles approches nécessaires pour le traitement des crises d’asthme — Futura sciences
“De la rhinite à l’ashtme?, GA²LEN” Oasis Allergies (newsletter of francophone patients’ associations in France and Belgium, member of EFA) N°70, Jan/Feb/Mar 2007
“De la rhinite à l’asthme? – une campagne GA²LEN”
www.boursica.com
http://fr.biz.yahoo.com
www.mobifrance.com
http://bouse.lepoint.fr
www.lelezard.com
www.skynet.be
www.capital.fr
“GA²LEN: de la rhinite à l’asthme”. Allergique.org, le journal des allergies, “Les Allergies” website of Assureurs prévention santé (French health insurers)
Allergies: vers un fléau du XXIe siècle? Science & Vie, May 2007 issue, 6 pages articles explaining allergies (Les clés poour coumprendre)
“Test à l’aspirine : C’est si facile, pourquoi s’en priver?” www.allergique.org – webarticle + newsletter + illustration drawing “test à l’aspirine: dangereux ?”
“La rhinite mène-t-elle à l’asthme? Campagne d’information” Oasis Allergies (newsletter of francophone patients’ associations in France and Belgium, member of EFA) N°70, Jan/Feb/Mar 2007

2006

EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria

Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, Kapp A, Kozel MM, Maurer M, Merk HF, Schafer T, Simon D, Vena GA, Wedi B; EAACI/GA2LEN/EDF. — Review article. Allergy Vol 61- N°3,

Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA²LEN)

Bousquet J, van Cauwenberge P, Aït Khaled N, Bachert C, Baena-Cagnani CE, Bouchard J, Bunnag C, Canonica GW, Carlsen KH, Chen YZ, Cruz AA, Custovic A, Demoly P, Dubakiene R, Durham S, Fokkens W, Howarth P, Kemp J, Kowalski ML, Kvedariene V, Lipworth B, Lockey R, Lund V, Mavale-Manuel S, Meltzer EO, Mullol J, Naclerio R, Nekam K, Ohta K, Papadopoulos N, Passalacqua G, Pawankar R, Popov T, Potter P, Price D, Scadding G, Simons FE, Spicak V, Valovirta E, Wang DY, Yawn B, Yusuf O; GA2LEN. Allergy. 2006 Sep;61(9):1086-96. Review.

EAACI / GA²LEN Position Paper: Present status of the atopy patch test

K. Turjanmaa, U. Darsow, B. Niggemann, F. Rancé, T. Vanto, T. Werfel. Allergy (2006),61:1377-1384

Rhinitis and asthma in athletes: an ARIA document in collaboration with GA²LEN

Bonini S, Bonini M, Bousquet J, Brusasco V, Canonica GW, Carlsen KH, Corbetta L, Cummiskey J, Delgado L, Del Giacco SR, Haahtela T, Jaeger S, Moretti C, Palange P, Passalacqua G, Passali D, Pedersen BK, Popov T, Rasi G, Ventura MT, Vignola AM. Allergy. 2006 Jun;61(6):681-92. Review.

Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA²LEN project

Bousquet J, Anto JM, Bachert C, Bousquet PJ, Colombo P, Crameri R, Daëron M, Fokkens W, Leynaert B, Lahoz C, Maurer M, Passalacqua G, Valenta R, van Hage M, Van Ree R. Allergy. 2006 Jun;61(6):671-80.

Global Allergy and Asthma European Network (GA²LEN)–a focus for paediatric allergy research

Warner JO. Pediatr. Allergy Immunol. 2006 May;17(3):163.

EAACI/GA²LEN/EDF guideline: management of urticaria

Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, Kapp A, Kozel MM, Maurer M, Merk HF, Schäfer T, Simon D, Vena GA, Wedi B; EAACI/GA2LEN/EDF. Allergy. 2006 Mar;61(3):321-31. Review.

EAACI/GA²LEN/EDF guideline: definition, classification and diagnosis of urticaria

Mentions

Germany

“Allergy, Europe’s 21st century epidemic”
GA²LEN Press conference and Plenary session – Medical News Today 2 million visitors a month Media invitation
Evening programme broadcast on Allergy – German French TV Channel ARTE – sequences from GA²LEN Ex Com members at WAC Munich + Call in campaign / Hotline for questions on allergy and on GA²LEN – Press conference foreseen to launch this programme
Arte, Thema, ZDF – Documentaire
« Les allergies, ces maladies mystérieuses »
« Allergies : les enfants, premières victimes »
« L’allergie, une pathologie souvent pas prise au sérieux » TC Nachweiz
Interview of T. Zuberbier, Secretary General GA²LEN, about GA²LEN and prevalence and new outcomes on allergy and asthma – ARTE
Wie kann man Kinder vor Allergien schützen? – GA²LEN Jahreskonferenz ALLERGO JOURNAL 2006, 15 – pp 316-320
FRANKFURTER RUNDSCHAU: Zigaretten können schon beim Ungeborenen Allergien auslösen
Germany, Austria, Switzerland. Der Tagesspiegel (134 000 issues); Frankfurter Rundschau redaktion (180 000 issues), seite 40; Oranienburger Generalanzeiger : Allergien im Mutterleib; Publikation Lausitzer Rundchau Wochenende; Giessener Allgemeine Redaktion, rubrik Medizin Gesundheit, seite 22; Lauziter Rundschau Märkische Oderzeitung www.moz.de/index.php/Moz/Article
Zigaretten können schon beim Ungeborenen Allergien auslösen
Germany – Arztliche Praxis, 57.000 visitors; www.aponet.de;
RBB – Interview Torsten Zuberbier on allergies and therapies
PRESS CONFERENCE 31 March, Berlin (annual conference) – Einladung zur Pressekonferenz / 100 Jahre Allergie – Jahres Konferenz des Europäischen Allergie und Asthmanetzwerk GA²LEN
Speakers: Paul van Cauwenberge – Torsten Zuberbier – Peter Burney
Germany + European coverage
Press Conference announced in
www.medicalnewstoday.com (2 million visitors a month)
www.presseportal.de
www.juraforum.de/jura/news
www.wallstreet-online.de
www.campus-med.de
www.softlook.de
www.invertia.com
http://ec.europa.eu/research/press/2006/pr1403en.cfm
ECARF website
Neue Erkenntnisse zur Entstehung von Allergien: Jahreskonferenz des Europaischen Allergie – und Asthmanetzwerks GA²LEN
www.med-magazin.de (more than 1000 visitors a day)
www.med-kolleg.de/news/n2750805306.html
www.austropharm.at/apa_show.html
www.campu-med.de
www.med-kolleg.de
Interviews of GA²LEN opinion leaders for a Large and in-depth report into asthma and COPD on behalf of Cambridge Pharma, a UK-based publisher that is a subsidiary of IMS Health.
Schon jeder Dritte leidet unter Allergien – dradio www.dradio.de
Allergien: Europäische Datenbank soll neue Erkenntnisse bringen
Neue Studie bewertet 50 Faktoren, die Allergien bei Kindern beeinflussen – online coverage
www.allergieforum.de
www.campus-med.de
www.med-kolleg.de
GA²LEN: Neue Erkenntnisse zur Entstehung – Akt Dermatol; Allergikus
Allergien: Forscher entwickeln Datenbank zur Bewertung von Einglussfaktoren – www.pressetext.de
2015 leidet jeder Zweite in Europa an einer Allergie – Medizinauskunft – www.medizinauskunft.de
Databank zu Allergien im Kindersalter – ALLUM: Allergie – Umwelt – Gesundheit (Allergy, Environment, Health)
Allergien: Forscher entwickeln Datenbank zur Bewertung von Einglussfaktoren – www.journalmed.de
www.journalmed.de
ZDF: Allergien in der Datenbank – Berliner Charité sammelt Studien von Tausenden Kindern www.Heute.de
Mehr Schutz fuer Kinder vor Allergien / Berliner Charité forscht mit Allergie-Databank
www.tagesschau.de
Neue Databank zu Allergien – Aertz Zeitung
www.aerztezeitung.de

Europe

Tackling allergies and asthma with a Europe-wide approach – EURONEWS, Futuris programme
Europe – 15 Million viewers – 7 languages (English, German, French, Italian, Spanish, Portug., Polish), available on webstreaming (TVLink)
New insights into the development of allergies – www.nieuwsbank.nl
GA²LEN partners in EU application to improve paediatric asthma management (application on 19 May)
El servicio de alergología de la CUN es aceptada como miembro de una red europea de excelencia asistencial – www.diariomedico.com
Academy News press release – AAAAI – GA²LEN, a growing network – International – more than 6,000 members in the USA, Canada & 60 other countries
Studies help rank 50 factors influencing child allergy – AlphaGalileo: 6000 science journalists registered
MedicalNewsTodays: 2 millions individual viewers a month
7me PCRD: Buzek soutient la recherche sur les maladies allergiques – Euractiv : EU News, Policy positions and EU Actors on line

2005

EU Forum – Spreading excellence in allergy and asthma – the GA²LEN project

van Cauwenberge P., Watelet JB, Van Zele R, Bousquet J, Burney P, Zuberbier T, GA²LEN partners, Allergy 2005:60 858-864

EU Forum – In search of a new paradigm: mechanisms of sensitization & elicitation of food allergy

L.K Poulsen, Allergy 2005:60 549-558

A new tool to assess and monitor the burden of chronic cough on quality of life

Baiardini I, Braido F, Fassio O, et al., Allergy2005, 60:482-8

EU Forum – The SAFE project

K. Hoffmann-Sommergruber & SAFE Consortium – Allergy 2005:60 436-442

EU Forum – Evaluation of cost of disease, assessing the burden to society of asthma in children in the EU

M.E van den Akker van Marle, J. Buil, S.B Detmar , Allergy 2005:60

Standard skin prick testing and sensitization to inhalant allergens across Europe – a survey from the GA²LEN network

Heinzerling, L., Frew, A. J., Bindslev-Jensen, C., Bonini, S., Bousquet, J., Bresciani, M., Carlsen, K.-H., van Cauwenberge, P., Darsow, U., Fokkens, W. J., Haahtela, T., van Hoecke, H., Jessberger, B., Kowalski, M. L., Kopp, T., Lahoz, C. N., Lodrup Carlsen, K. C., Papadopoulos, N. G., Ring, J., Schmid-Grendelmeier, P., Vignola, A. M., Wöhrl, S. and Zuberbier, T. (2005), Allergy, 60: 1287–1300. doi: 10.1111/j.1398-9995.2005.00895.x

GA²LEN: coordinated research

Muñoz-López F. Allergol Immunopathol (Madr). 2005 Sep-Oct;33(5):243-4.

GA²LEN–The Global Allergy and Asthma European Network

Frew AJ. Clin Exp Allergy. 2005 Feb;35(2):122-5.

Mentions

Germany

THE ELSO GAZETTE on the web, Fostering scientific excellence in Europe
HAUTNAH DERMATOLOGIE: Bald europäische Leitlinien für Urtikaria, www.hautnah-dermatologie.de/nachrichten/2004/06/urtikaria.php
MED-KOLLEG.DE: Internationales Expertentreffen Urtikaria 2004, www.med-kolleg.de/news/n2750599290.html
ALLERGO JOURNAL: Neue europäische Stiftung für Allergieforschung, January 2005
“GA²LEN, an opportunity to achieve excellence” – Press release in English and German
http://www.nachrichten-weltweit.de (08.07.05)
http://www.nachrichten-weltweit.de (08.07.05)
http://aktien.onvista.de (08.07.05)
http://www.presseportal.de (08.07.05)
http://www.optinews.de (08.07.05)
http://www.gelon.de (08.07.05)
http://www.vc-pro.de (08.07.05)
http://www.news-board.de (08.07.05)
http://www.juchu.de (08.07.05)
http://www.unternehmennews.de (08.07.05)
http://www.campus-med.de (08.07.05)
http://www.wallstreet-online.de (08.07.05)
„New Pan-European Surveillance System for inhalant allergens “. Press article sent on the European media wire – available for the World Allergy Day, Friday 8 July
http://aktien.onvista.de (08.07.05)
http://www.presseportal.de (08.07.05)
http://www.optinews.de (08.07.05)
http://www.gelon.de (08.07.05)
http://www.vc-pro.de (08.07.05)
http://www.news-board.de (08.07.05)
http://www.juchu.de (08.07.05)
http://www.unternehmennews.de (08.07.05)
http://www.campus-med.de (08.07.05)
http://www.wallstreet-online.de (08.07.05)
http://www.campus-med.de (08.07.05)
http://www.wallstreet-online.de (08.07.05)
“Histamine receptors are hot in immunopharmacology” C. Akdis, F. E. Simons, European Journal of Pharmacology, European Journal of pharmacology, 2006 Jan 28 – (Review Article in Press)

2004

Europe

GA²LEN Launch media coverage LA LIBRE Belgique, Newspaper, Un réseau d’excellence pour combattre les allergies (Laurence Dardenne)
THE SCIENTIST / BIOMED CENTRAL, Europe’s big wheeze underway (http://www.biomedcentral.com/news/20040212/03)
GA²LEN Launch media coverage BBC Breakfast TV, TV morning programme, P. Burney
GA²LEN Launch media coverage THE SCOTSMAN, Allergy level – Soaring levels of asthma and allergies
EUPOLITIX.COM, Brussels coughs up allergy cash, http://www.eupolitix.com/EN/News/200402/ce09fb0c-d4d6-4b4b-8bfb-f9771c558ab5.htm
EAACI, 2nd International Consensus Meeting on Urticaria, www.eaaci.net/site/content.php?11=64&sel=383
GA²LEN Launch media coverage ALERGIA ASTMA IMMUNOLOGICA: GA²LEN- Europejska Siec Doskonatosci w Alergii
BIVDA.CO.UK, World asthma day, http://www.bivda.co.uk/news/index.cfm?ccs=115&cs=934

UK

GA²LEN Launch media coverage THE GUARDIAN, Education Guardian Weekly, Is your home bugging you? – Teaching children about allergies – (Jerome Monahan)
TIMES ONLINE, Allergy alert: deep breath, www.timesonline.co.uk/article/0,,8123-1012639,00.html